Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-08 Sale |
2023-09-08 4:00 pm |
Surface Oncology Inc. | SURF | Sigal Charles Elliott Director |
45,453 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-03-01 Purchase |
2023-03-02 4:27 pm |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
2,500 | $22.73 | $56,816 | 19,779 (Indirect Direct) |
View |
| 2023-01-05 Purchase |
2023-01-09 11:51 am |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
2,500 | $24.96 | $62,396 | 17,279 (Indirect Direct) |
View |
| 2023-01-03 Purchase |
2023-01-05 5:00 pm |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
5,000 | $25.43 | $127,129 | 14,779 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-30 Option Award |
2024-06-03 12:18 pm |
2025-05-30 2034-05-29 |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
24,000 | $0 | 49,806 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-20 4:08 pm |
2025-05-16 2034-05-16 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director |
5,228 | $0 | 5,228 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:02 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director |
933,317 | $0 | 933,317 (Direct) |
View |
| 2023-05-22 Option Award |
2023-05-24 2:33 pm |
2024-05-22 2033-05-21 |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
18,081 | $0 | 37,860 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-19 4:06 pm |
2024-05-18 2033-05-18 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director |
3,454 | $0 | 3,454 (Direct) |
View |
| 2022-08-22 Option Award |
2022-08-24 4:08 pm |
N/A 2032-08-22 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director |
4,456 | $0 | 4,456 (Direct) |
View |
Ownership |
2022-08-24 4:07 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director |
0 | $0 | 2,000 (Indirect) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:01 pm |
2023-07-01 2032-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director |
737,050 | $0 | 737,050 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 8:00 pm |
N/A 2032-06-08 |
Surface Oncology Inc. | SURF | Sigal Charles Elliott Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 6:09 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
19,215 | $0 | 22,589 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:01 pm |
2022-07-01 2031-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director |
474,385 | $0 | 474,385 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 4:30 pm |
N/A 2031-06-08 |
Surface Oncology Inc. | SURF | Sigal Charles Elliott Director |
17,700 | $0 | 17,700 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-25 4:48 pm |
2022-05-21 2031-05-20 |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
10,122 | $0 | 10,122 (Direct) |
View |
| 2020-07-10 Option Award(A) |
2020-10-13 7:16 pm |
N/A 2030-07-09 |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
28,394 | $0 | 28,394 (Direct) |
View |
| 2020-07-10 Option Award |
2020-07-14 8:22 pm |
N/A 2030-07-10 |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
57,777 | $0 | 57,777 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-01 5:07 pm |
2021-07-01 2030-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director |
184,258 | $0 | 184,258 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-12 08:00 am |
N/A 2030-06-10 |
Surface Oncology Inc. | SURF | Sigal Charles Elliott Director |
12,000 | $0 | 12,000 (Direct) |
View |